Diebold Nixdorf, Incorporated

WIN.SW plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, WIN.SW stands at 8.1B. In comparison, EMR.SW has a market cap of 65.8B. Regarding current trading prices, WIN.SW is priced at CHF 66.40, while EMR.SW trades at CHF 67.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

WIN.SW currently has a P/E ratio of -21.17, whereas EMR.SW's P/E ratio is 14.51. In terms of profitability, WIN.SW's ROE is +0.53%, compared to EMR.SW's ROE of +0.12%. Regarding short-term risk, WIN.SW and EMR.SW have similar daily volatility (0.00).Check EMR.SW's competition here

WIN.SW plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, WIN.SW stands at 8.1B. In comparison, GPRO.SW has a market cap of 150.9M. Regarding current trading prices, WIN.SW is priced at CHF 66.40, while GPRO.SW trades at CHF 5.48.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

WIN.SW currently has a P/E ratio of -21.17, whereas GPRO.SW's P/E ratio is 32.24. In terms of profitability, WIN.SW's ROE is +0.53%, compared to GPRO.SW's ROE of -0.89%. Regarding short-term risk, WIN.SW and GPRO.SW have similar daily volatility (0.00).Check GPRO.SW's competition here